Epigenetic mechanisms and drug discovery in rheumatology
David F Tough, Rab K Prinjha and Paul P Tak
DOI: https://doi.org/10.7861/clinmedicine.15-6-s64
Clin Med December 2015 David F Tough
AEpigenetics DPU, Immuno-inflammation Therapy Area, GlaxoSmithKline, Medicines Research Centre, Stevenage, UK;
Roles: principal scientific investigator
Rab K Prinjha
BEpigenetics DPU, Immuno-inflammation Therapy Area Unit, GlaxoSmithKline, Medicines Research Centre, Stevenage, UK;
Roles: vice president and head
Paul P Tak
CImmuno-inflammation Therapy Area Unit, GlaxoSmithKline, Medicines Research Centre, Stevenage, UK
Roles: senior vice president and head
Article Information
vol. 15 no. Suppl 6 s64-s71
PubMed:
Published By:
Print ISSN:
Online ISSN:
History:
- Published online December 3, 2015.
Copyright & Usage:
© Royal College of Physicians 2015. All rights reserved.
Author Information
- David F Tough, principal scientific investigatorA,
- Rab K Prinjha, vice president and headB and
- Paul P Tak, senior vice president and headC⇑
- AEpigenetics DPU, Immuno-inflammation Therapy Area, GlaxoSmithKline, Medicines Research Centre, Stevenage, UK;
- BEpigenetics DPU, Immuno-inflammation Therapy Area Unit, GlaxoSmithKline, Medicines Research Centre, Stevenage, UK;
- CImmuno-inflammation Therapy Area Unit, GlaxoSmithKline, Medicines Research Centre, Stevenage, UK
- Address for correspondence: Dr PP Tak, Immuno-inflammation Therapy Area Unit, GlaxoSmithKline, Medicines Research Centre, Stevenage SG1 2NY, UK Email: paul-peter.x.tak{at}gsk.com
Article usage
Article Tools
Epigenetic mechanisms and drug discovery in rheumatology
David F Tough, Rab K Prinjha, Paul P Tak
Clinical Medicine Dec 2015, 15 (Suppl 6) s64-s71; DOI: 10.7861/clinmedicine.15-6-s64
Citation Manager Formats
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.